SARS-CoV-2-specific CD8( ) T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph

Louise C Rowntree; Jan Petersen; Jennifer A Juno; Priyanka Chaurasia; Kathleen Wragg; Marios Koutsakos; Luca Hensen; Adam K Wheatley; Stephen J Kent; Jamie Rossjohn; Katherine Kedzierska; Thi HO Nguyen

Journal article

SARS-CoV-2-specific CD8( ) T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph

Louise C Rowntree, Jan Petersen, Jennifer A Juno, Priyanka Chaurasia, Kathleen Wragg, Marios Koutsakos, Luca Hensen, Adam K Wheatley, Stephen J Kent, Jamie Rossjohn, Katherine Kedzierska, Thi HO Nguyen

IMMUNOLOGY AND CELL BIOLOGY | WILEY | Published : 2021

DOI: 10.1111/imcb.12482

Abstract

In-depth understanding of human T-cell-mediated immunity in coronavirus disease 2019 (COVID-19) is needed if we are to optimize vaccine strategies and immunotherapies. Identification of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cell epitopes and generation of peptide-human leukocyte antigen (peptide-HLA) tetramers facilitate direct ex vivo analyses of SARS-CoV-2-specific T cells and their T-cell receptor (TCR) repertoires. We utilized a combination of peptide prediction and in vitro peptide stimulation to validate novel SARS-CoV-2 epitopes restricted by HLA-A*24:02, one of the most prominent HLA class I alleles, especially in Indigenous and Asian populations. Of the pept..

View full abstract

University of Melbourne Researchers

Jennifer Juno Author Microbiology and Immunology

Adam Wheatley Author Microbiology and Immunology

Stephen Kent Author Microbiology and Immunology

Louise Rowntree Author Microbiology and Immunology

Oanh Nguyen Author Microbiology and Immunology

Related Projects (8)

CHARACTERIZATION OF MAIT CELL FUNCTION AND FREQUENCY AT THE RECTAL MUCOSA AND GASTROINTESTINAL TRACT DURING HIV/SIV INFECTION

This project focuses on determining how HIV infection alters the function of rare, unconventional immune cell populations in the gastrointes..

IMPROVED HIV AND INFLUENZA VACCINES

This fellowship is to support Professor Stephen Kent in generating new advances in vaccines to prevent HIV (the cause of AIDS) and Influenza..

RATIONAL DESIGN OF NOVEL VACCINES FOR THE CONTROL OF INFLUENZA B

ADDRESSING THE MAJOR CHALLENGES IN HIV VACCINE AND CURE RESEARCH

HIV remains one of the defining global health challenge of our times. 37 million people are living with HIV with 2 million new infections ea..

ADVANCING INFLUENZA VACCINES FOR BROAD AND DURABLE PROTECTION

HARNESSING UNIVERSAL IMMUNITY TO INFLUENZA

Understanding immune responses to severe influenza virus infection and vaccination in humans

Understanding immunity to influenza B viruses for a rationally designed universal vaccine

Grants

Awarded by NHMRC Leadership Investigator Grant

Awarded by NHMRC

Awarded by NHMRC Emerging Leadership Level 1 Investigator Grants

Awarded by NHMRC Early Career Fellowship (ECF)

Awarded by Victorian Government MRFF award

Awarded by MRFF Award

Funding Acknowledgements

We thank all the participants involved in the study, Robyn Esterbauer, Hannah Kelly, Jane Batten and Helen Kent, for support with the cohort. We thank Anthony Purcell for the C1R.A*24:02 cell line. This work was supported by the NHMRC Leadership Investigator Grant to KK (#1173871); Research Grants Council of the Hong Kong Special Administrative Region; China (#T11-712/19-N) to KK; the Victorian Government MRFF award (#2002073) to SJK and AKW; MRFF Award (#1202445) to KK; MRFF Award (#2005544) to KK, SJK, JAJ and AKW; NHMRC program grant #1149990 (SJK) and NHMRC project grant #1162760 (AKW). THON, MK and AKW were supported by NHMRC Emerging Leadership Level 1 Investigator Grants (#1194036 THON; #1195698 MK; #1173433 AKW), SJK was supported by NHMRC Senior Principal Research Fellowship (#1136322). JR is supported by an ARC Laureate fellowship. LH is supported by the Melbourne International Research Scholarship (MIRS) and the Melbourne International Fee Remission Scholarship (MIFRS) from The University of Melbourne. JAJ is supported by an NHMRC Early Career Fellowship (ECF) (#1123673).